基于Notch信号通路探讨β-榄香烯逆转肺腺癌耐药机制的研究
作者:
作者单位:

1.海安市中医院 肿瘤科,江苏 南通,226600;2.南通市中医院,江苏 南通,226001;3.南京中医药大学,江苏 南京,210023

作者简介:

濮忠建,男,硕士,主治中医师,研究方向:肿瘤的中西医结合治疗。

通讯作者:

王亚军,男,主任医师,研究方向:肿瘤的中西医结合治疗。

中图分类号:

R734.2

基金项目:

★南通市中医医疗联盟课题(TZYK201825)。


Study on the mechanism of β-elemene reversing drug resistance of lung adenocarcinoma based on Notch signaling pathway
Author:
Affiliation:

1.Department of Oncology, Hai'an Hospital of Traditional Chinese Medicine, Nantong, Jiangsu, 226600, China;2.Nantong Hospital of Traditional Chinese Medicine, Nantong, Jiangsu, 226001, China;3.Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, China

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 基于Notch信号通路,探讨β-榄香烯逆转肺腺癌耐药的机制。方法 选择对A549/DDP细胞无细胞毒性的β-榄香烯浓度处理A549/DDP细胞,设β-榄香烯组与对照组,两组细胞均给予不同浓度的DDP(0.25、0.5、1、2、4、8、16、32 μg·mL-1)处理24 h,MTT法检测细胞活力并计算IC50,流式细胞仪检测细胞凋亡,Western blotting检测凋亡相关蛋白(cleaved-caspase 3、cleaved-caspase 9)、耐药相关蛋白(P-gp、survivin、p21)及Notch信号通路蛋白(Notch1、Hes1、Hey2)的表达。A549/DDP细胞在β-榄香烯处理的基础上,联合1 μg·mL-1 Notch信号通路激活剂rhNF-κB处理,比较两组的IC50,Western blotting检测P-gp以及Notch1、Hes1、Hey2的表达。结果 当β-榄香烯浓度低于20 μg·mL-1时,其对A549/DDP细胞的抑制率小于10%,无细胞毒性。β-榄香烯组DDP的IC50显著低于对照组(t=14.712, P<0.05),逆转倍数为4.452倍。β-榄香烯组细胞凋亡率以及凋亡相关蛋白cleaved-caspase 3和cleaved-caspase 9的表达水平均高于对照组,差异有统计学意义(P<0.05)。β-榄香烯组P-gp、survivin蛋白相对表达量低于对照组,而p21蛋白相对表达量高于对照组,差异均有统计学意义(P<0.05)。β-榄香烯组Notch1、Hes1、Hey2蛋白相对表达量均低于对照组,差异有统计学意义(P<0.05)。β-榄香烯+ rhNF-κB组DDP的IC50以及P-gp、Notch1、Hes1、Hey2蛋白表达水平均高于β-榄香烯组,差异有统计学意义(P<0.05)。结论 β-榄香烯可通过抑制Notch信号通路促进A549/DDP细胞凋亡,并逆转肺腺癌耐药。

    Abstract:

    Objective To explore the mechanism of β-elemene reversing drug resistance of lung adenocarcinoma based on Notch signaling pathway.Methods A549/DDP cells were treated with β-elemene in a concentration that was not cytotoxic to A549/DDP cells. Designed β-elemene group and control group. Cells in the two groups were given different concentrations (0.25, 0.5, 1, 2, 4, 8, 16, 32 μg·mL-1) of DDP for 24 h. Cell viability and the IC50 were measured by MTT, and cell apoptosis were detected by flow cytometry. The apoptosis-related proteins (cleaved-caspase 3, cleaved-caspase 9), drug resistance-associated proteins (P-gp, survivin, p21) and Notch signaling pathway proteins (Notch1, Hes1, Hey2) were detected by Western blotting. After A549/DDP cells were treated with β-elemene +1 μg·mL-1 Notch signaling pathway activator rhNF-κB, compare the IC50 between the β-elemene group and β-elemene + rhNF-κB group, and detect the proteins P-gp, Notch1, Hes1 and Hey2 with Western blotting.Results When the concentration of β-elemene was lower than 20 μg·mL-1, the inhibition rate of A549/DDP cells was lower than 10%, showing no cytotoxicity. The IC50 of DDP in A549/DDP cells in β-elemene group was lower than that in control group (t=14.712, P<0.05), and the reversal fold was 4.452 times. The apoptosis rate in the β-elemene group was higher than in the control group, and the expression levels of apoptosis-related proteins (cleaved-caspase 3 and cleaved-caspase 9) were higher than those of the control group (P<0.05). The relative expression levels of P-gp and survivin proteins in β-elemene group were lower than in control group, and the relative expression level of p21 protein was higher in β-elemene group than in control group (P<0.05). The relative expression levels of Notch1, Hes1 and Hey2 proteins in β-elemene group was lower than that in control group (P<0.05). The A549/DDP cells in β-elemene + rhNF-κB group had a higher DDP IC50 than that in the β-elemene group, and the expression levels of P-gp, Notch1, Hes1, Hey2 proteins were higher than those of the β-elemene group (P<0.05).Conclusion β-elemene can promote apoptosis of A549/DDP cells by inhibiting Notch signaling pathway, so that can reverse the drug resistance of lung adenocarcinoma.

    参考文献
    相似文献
    引证文献
引用本文

濮忠建,顾小侠,张静知,韦琪,孙元鹏,朱时林,王亚军.基于Notch信号通路探讨β-榄香烯逆转肺腺癌耐药机制的研究[J].肿瘤药学,2022,(1):53-59 ( in Chinese)

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2020-04-10
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-03-15
  • 出版日期:
我要投稿 杂志简介 杂志简介 二维码
TOP
×
《肿瘤药学》
《肿瘤药学》编辑部打假维权声明